H.T. Eich
YOU?
Author Swipe
S819 PET AFTER 2 CYCLES OF ABVD IN PATIENTS WITH EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA TREATED WITHIN THE PHASE 3 GHSG HD16 STUDY Open
Background: NLPHL is a rare, distinct and indolent subtype of Hodgkin lymphoma. At present, evidence to guide treatment decision-making in NLPHL comes from a paucity of prospective and retrospective studies performed over the past decades.…